The independent effect of exercise on biopsy-proven non-alcoholic fatty liver disease: A systematic review
2
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Non-alcoholic fatty liver disease (NAFLD) is the most common cause of chronic liver disease worldwide. Although previous studies have demonstrated that exercise independently reduces hepatic steatosis measured by imaging modalities in NAFLD, the effect of exercise on histological endpoints remains unclear. We aimed to conduct a systematic review of the independent effect of exercise on hepatic steatosis, steatohepatitis, and liver fibrosis as measured by histological assessment or non-invasive tests (NITs) in biopsy-proven NAFLD. A systematic literature search of PubMed, Embase, and Web of Science databases was performed using keywords related to exercise, NAFLD, and biopsy. Articles were selected based on the following inclusion criteria: (1) involved human subjects with biopsy-proven NAFLD, (2) analyzed the independent effect of exercise, (3) assessed changes in hepatic steatosis, steatohepatitis, or liver fibrosis via either histological evaluation or NITs, and (4) were original research studies. We identified a total of six studies that analyzed the independent effect of exercise on histological endpoints in biopsy-proven NAFLD. Two randomized controlled trials (RCTs) did not detect significant histological improvement following exercise interventions, while other non-randomized interventional studies showed that exercise reduces hepatocyte ballooning and liver fibrosis. In addition, five studies assessed NIT outcomes, collectively demonstrating that exercise improves hepatic steatosis measured by magnetic resonance imaging-based techniques but not serum biomarkers for steatohepatitis and liver fibrosis. Additional large RCTs and meta-analyses are warranted to investigate the independent effect of exercise on histological and clinical outcome endpoints in NAFLD.
Abstract
Non-alcoholic fatty liver disease (NAFLD) is the most common cause of chronic liver disease worldwide. Although previous studies have demonstrated that exercise independently reduces hepatic steatosis measured by imaging modalities in NAFLD, the effect of exercise on histological endpoints remains unclear. We aimed to conduct a systematic review of the independent effect of exercise on hepatic steatosis, steatohepatitis, and liver fibrosis as measured by histological assessment or non-invasive tests (NITs) in biopsy-proven NAFLD. A systematic literature search of PubMed, Embase, and Web of Science databases was performed using keywords related to exercise, NAFLD, and biopsy. Articles were selected based on the following inclusion criteria: (1) involved human subjects with biopsy-proven NAFLD, (2) analyzed the independent effect of exercise, (3) assessed changes in hepatic steatosis, steatohepatitis, or liver fibrosis via either histological evaluation or NITs, and (4) were original research studies. We identified a total of six studies that analyzed the independent effect of exercise on histological endpoints in biopsy-proven NAFLD. Two randomized controlled trials (RCTs) did not detect significant histological improvement following exercise interventions, while other non-randomized interventional studies showed that exercise reduces hepatocyte ballooning and liver fibrosis. In addition, five studies assessed NIT outcomes, collectively demonstrating that exercise improves hepatic steatosis measured by magnetic resonance imaging-based techniques but not serum biomarkers for steatohepatitis and liver fibrosis. Additional large RCTs and meta-analyses are warranted to investigate the independent effect of exercise on histological and clinical outcome endpoints in NAFLD.
참고문헌 (34)
- Cheng Han Ng, "Nonalcoholic fatty liver disease versus metabolic-associated fatty liver disease: Prevalence, outcomes and implications of a change in name", Clinical and Molecular Hepatology, 28(4), pp.790~801 (2022), 대한간학회
- Seong Hee Kang, "From nonalcoholic fatty liver disease to metabolic-associated fatty liver disease: Big wave or ripple?", Clinical and Molecular Hepatology, 27(2), pp.257~269 (2021), 대한간학회[DOI]
- Diehl AM, "Cause, pathogenesis, and treatment of nonalcoholic steatohepatitis", N Engl J Med, 377, pp.2063~2072 (2017)
- Younossi Z, "Nonalcoholic steatohepatitis is the fastest growing cause of hepatocellular carcinoma in liver transplant candidates", Clin Gastroenterol Hepatol, 17, pp.748~755 (2019)
- Younossi Z, "Global burden of NAFLD and NASH : trends, predictions, risk factors and prevention", Nat Rev Gastroenterol Hepatol, 15, pp.11~20 (2018)
- Michael H. Le, "Forecasted 2040 global prevalence of nonalcoholic fatty liver disease using hierarchical bayesian approach", Clinical and Molecular Hepatology, 28(4), pp.841~850 (2022), 대한간학회
- European Association for the Study of the Liver(EASL), "EASL-EASD-EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease", J Hepatol, 64, pp.1388~1402 (2016)
- 강성희, "KASL clinical practice guidelines: Management of nonalcoholic fatty liver disease", Clinical and Molecular Hepatology, 27(3), pp.363~401 (2021), 대한간학회
- Sullivan S, "Randomized trial of exercise effect on intrahepatic triglyceride content and lipid kinetics in nonalcoholic fatty liver disease", Hepatology, 55, pp.1738~1745 (2012)
- Johnson NA, "Aerobic exercise training reduces hepatic and visceral lipids in obese individuals without weight loss", Hepatology, 50, pp.1105~1112 (2009)
- Goodpaster BH, "Effects of diet and physical activity interventions on weight loss and cardiometabolic risk factors in severely obese adults : a randomized trial", JAMA, 304, pp.1795~1802 (2010)
- Hallsworth K, "Resistance exercise reduces liver fat and its mediators in non-alcoholic fatty liver disease independent of weight loss", Gut, 60, pp.1278~1283 (2011)
- Keating SE, "Exercise and non-alcoholic fatty liver disease : a systematic review and metaanalysis", J Hepatol, 57, pp.157~166 (2012)
- Sabag A, "The effect of high-intensity interval training vs moderateintensity continuous training on liver fat : a systematic review and meta-analysis", J Clin Endocrinol Metab, 107, pp.862~881 (2022)
- Rethlefsen ML, "PRISMA-S : an extension to the PRISMA statement for reporting literature searches in systematic reviews", Syst Rev, 10, pp.39~ (2021)
- Hickman IJ, "A pilot randomised study of the metabolic and histological effects of exercise in non-alcoholic steatohepatitis", J Diabetes Metab, 4, pp.300~ (2013)
- Eckard C, "Prospective histopathologic evaluation of lifestyle modification in nonalcoholic fatty liver disease : a randomized trial", Therap Adv Gastroenterol, 6, pp.249~259 (2013)
- Naimimohasses S, "Differential effects of dietary versus exercise intervention on intrahepatic MAIT cells and histological features of NAFLD", Nutrients, 14, pp.2198~ (2022)
- O’Gorman P, "Improvement in histological endpoints of MAFLD following a 12-week aerobic exercise intervention", Aliment Pharmacol Ther, 52, pp.1387~1398 (2020)
- Kistler KD, "Physical activity recommendations, exercise intensity, and histological severity of nonalcoholic fatty liver disease", Am J Gastroenterol, 106, pp.460~468 (2011)
- Lahelma M, "Assessment of lifestyle factors helps to identify liver fibrosis due to non-alcoholic fatty liver disease in obesity", Nutrients, 13, pp.169~ (2021)
- Rezende RE, "Randomized clinical trial : benefits of aerobic physical activity for 24 weeks in postmenopausal women with nonalcoholic fatty liver disease", Menopause, 23, pp.876~883 (2016)
- Stine JG, "NASHFit : a randomized controlled trial of an exercise training program to reduce clotting risk in patients with NASH", Hepatology, 76, pp.172~185 (2022)
- Houghton D, "Exercise reduces liver lipids and visceral adiposity in patients with nonalcoholic steatohepatitis in a randomized controlled trial", Clin Gastroenterol Hepatol, 15, pp.96~102 (2017)
- Tamaki N, "Clinical utility of 30% relative decline in MRIPDFF in predicting fibrosis regression in non-alcoholic fatty liver disease", Gut, 71, pp.983~990 (2022)
- Richter EA, "AMPK and the biochemistry of exercise : implications for human health and disease", Biochem J, 418, pp.261~275 (2009)
- Guo R, "Beneficial mechanisms of aerobic exercise on hepatic lipid metabolism in nonalcoholic fatty liver disease", Hepatobiliary Pancreat Dis Int, 14, pp.139~144 (2015)
- Petridou A, "Long-term exercise increases the DNA binding activity of peroxisome proliferator-activated receptor gamma in rat adipose tissue", Metabolism, 56, pp.1029~1036 (2007)
- Kawanishi N, "Exercise training attenuates hepatic inflammation, fibrosis and macrophage infiltration during diet induced-obesity in mice", Brain Behav Immun, 26, pp.931~941 (2012)
- Imajo K, "Magnetic resonance imaging more accurately classifies steatosis and fibrosis in patients with nonalcoholic fatty liver disease than transient elastography", Gastroenterology, 150, pp.626~637 (2016)
- Park CC, "Magnetic resonance elastography vs transient elastography in detection of fibrosis and noninvasive measurement of steatosis in patients with biopsy-proven nonalcoholic fatty liver disease", Gastroenterology, 152, pp.598~607 (2017)
- Kim D, "Physical activity, measured objectively, is associated with lower mortality in patients with nonalcoholic fatty liver disease", Clin Gastroenterol Hepatol, 19, pp.1240~1247 (2021)
- Baumeister SE, "Association between physical activity and risk of hepatobiliary cancers : a multinational cohort study", J Hepatol, 70, pp.885~892 (2019)
- Pugh CJ, "Exercise-induced improvements in liver fat and endothelial function are not sustained 12 months following cessation of exercise supervision in nonalcoholic fatty liver disease", Int J Obes(Lond), 40, pp.1927~1930 (2016)